Mapping/Ablation

It is unrealistic to expect zero complications from an invasive procedure. It is also important to learn that trying to lower the rate of serious adverse events from 2% to 1% in the EP lab can require much more than twice the effort.

Gene therapy targeting the underlying desmosomal mutation and approaches to prevent myocardial fibrosis independent of the specific genetic defect by increasing cardiac levels of FGF21 may be on the horizon for patients with ARVC.

Sarah Vanderhoff, MSN, RN, and Andrew Feltgen, RT(R), describe the development, structure, and outcomes of Scripps’ Interventional Cardiology Rad Tech Transition Program.

It is surprising that in the latest atrial fibrillation guideline, not a single antiarrhythmic drug is considered to have a class I indication.

As computer science has enjoyed groundbreaking advances that have transformed other sectors of society, the idea of its application in medicine has generated excitement over its potential to fill knowledge gaps.

Ketan Koranne, MD, and colleagues discuss their approach to vein of Marshall alcohol ablation, workflow and feasibility of establishing a program, and share 2 brief case studies.

The indications for catheter ablation of idiopathic PVCs should remain limited to patients with significant symptoms or baseline left ventricular dysfunction.

In this interview from Western AF 2024, we speak with Suneet Mittal, MD, from the Valley Health System on what it takes to move atrial fibrillation (AF) practice to the outpatient setting.